Navigating the path forward for evidence-based management of long COVID.
Saved in:
| Title: | Navigating the path forward for evidence-based management of long COVID. |
|---|---|
| Authors: | Breen JJ; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Eisinger RW; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Read SW; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Beigel J; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Palmore TN; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Menetski JP; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Adam SJ; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Geerling E; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Roy E; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Gerberding J; Foundation for the National Institutes of Health, North Bethesda, MD, USA., Marrazzo JM; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. jeanne.marrazzo@nih.gov. |
| Source: | Nature immunology [Nat Immunol] 2025 Apr; Vol. 26 (4), pp. 536-539. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
